Nicholas A. Saccomano - Apr 4, 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Signature
/s/ Rogan Nunn, by power of attorney
Stock symbol
OKUR
Transactions as of
Apr 4, 2025
Transactions value $
-$2,570
Form type
4
Date filed
4/8/2025, 05:32 PM
Previous filing
Jan 29, 2025
Next filing
Jun 25, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OKUR Class A Common Stock Sale -$1.19K -358 -7.86% $3.33 4.2K Apr 4, 2025 Direct F1, F2, F3
transaction OKUR Class A Common Stock Sale -$1.38K -516 -12.29% $2.67 3.68K Apr 7, 2025 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan.
F2 This transaction was executed in multiple trades at prices ranging from $3.10 to $3.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F4 This transaction was executed in multiple trades at prices ranging from $2.57 to $3.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.